One-pot aqueous synthesis of sub-10 nm responsive nanogels by Li, Luxian et al.
6534 Chem. Commun., 2013, 49, 6534--6536 This journal is c The Royal Society of Chemistry 2013
Cite this: Chem. Commun.,2013,
49, 6534
One-pot aqueous synthesis of sub-10 nm responsive
nanogels†
Luxian Li, Aiping Chang, Yumei Hu, Laiying Zhang and Weitai Wu*
A strategy involving free radical copolymerization of a difunctional
oligomer and a small-molecule crosslinker to give sub-10 nm
nanogels is proposed. These nanogels can adapt to surrounding
temperatures and regulate the release of a preloaded model
anticancer drug 5-fluorouracil.
Responsive polymer nanogels with three-dimensional crosslinked
network structure are very promising as drug carriers because of
their high stability, high loading capacity, and responsiveness to
environmental factors, which are unprecedented for common phar-
maceutical carriers.1 Recently, this novel family of nanomaterials has
attracted increasing attention for co-delivery of pharmaceuticals,
labels, and sensing agents towards simultaneous diagnosis, therapy,
and feedback.2 However in the current state of development, such
nanogel-based carriers have not yet reached clinical trials. One of the
reasons is that they typically need a fairly long time to degrade under
physiological conditions, resulting in potential particle accumulation
in the body, which may in turn cause long-term toxicity. Even in a
few cases where nanogels may degrade rapidly,1–3 questions about
the degradation mechanism, biodistribution, and toxicity remain.
One way to overcome these problems is to design nanogels with
sizes smaller than 10 nm, i.e., below which is demonstrated to be a
threshold for renal clearance.4 Generally, two strategies are widely
employed for preparing nanogels: (i) a top-down approach where
emulsion polymerization techniques are further refined and opti-
mized, leading to the development of micro-/mini-emulsion proce-
dures; (ii) a bottom-up approach which either relies on the synthesis
of discrete spherical macromolecules or the self-assembly of linear
block copolymers into polymeric micelles followed by chemical cross-
linking.5 In both of these two approaches, however, gels with typical
sizes ranging from 20 nm to several micrometers are obtained. As a
consequence, the ability to routinely prepare nanogels of sub-10 nm
is quite limited. Only recently, an approach developed by Mecerreyes’s
group and other groups led to nanogels with the size ranging between
3–15 nm by intra-chain crosslinking of macromolecules in an ultra-
dilute solution (ca. 105–106 mol L1);6 later, its preparation
efficiency was improved by combining a continuous addition strategy
and thermally activated benzocyclobutene coupling chemistry.7
Another approach developed by Jiang’s group involves free radical
polymerization of a small-molecule crosslinker divinylbenzene (DVB)
in a glassy polymer matrix of poly(4-vinylpyridine), owing to the
successful prohibition of aggregation between the primary nanogels
by the solid matrix.8 Despite the exciting progress, the challenge of
synthesizing sub-10 nm nanogels still remains. The sub-10 nm
nanogels fabricated by those multistep approaches also lack respon-
siveness to the changes in environmental factors. Moreover, no
attempt has yet been made to utilize sub-10 nm nanogels as carriers.
Herein, we report a novel one-pot aqueous approach (Fig. 1a; see
ESI† for the detailed experimental procedures) to synthesize the sub-
10 nm responsive nanogels, starting from poly(ethylene glycol)
dimethacrylate (PEGDMA, Mn E 550 g mol
1), which is a commer-
cially available difunctional oligomer that has been used for pre-
paring temperature-responsive polymers,9 and the small-molecule
crosslinker DVB. Unlike conventional approaches that focus on
controlling the diffusion rate of the reaction reagents (using ultra-
dilute solution6,7 or a solid matrix as the reaction medium8), we try
to exploit functional oligomers that are able to form polymers with
appropriate compact conformational characteristics, which are
favorable for the formation of the sub-10 nm nanogels.
More specifically, such a typical sub-10 nm nanogel (denoted
as SPN-1) can be synthesized by free radical copolymerization of
PEGDMA (4.2 103 mol L1) and DVB (2.8  103 mol L1) using
ammonium persulfate (APS; 4.5 103 mol L1) as an initiator in the
presence of sodium dodecyl sulfate (SDS; 7.1  103 mol L1, which
is below the critical micelle concentration of 8.0  103 mol L1
(ref. 10)) at 70.0 1C. We monitored the whole synthesis process using
in situ dynamic light scattering (DLS). As shown in Fig. 1b, two stages
can be observed after addition of the initiator into the reaction
mixture: (i) DLS intensity remained nearly the same in the first
ca. 10 min and then (ii) increased gradually and reached a stable
value within the reaction time of 7 h. It is possible that after the free
radical copolymerization was initiated at the reaction temperature of
70.0 1C, the poly(PEGDMA-co-DVB) fragments formed at the early
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stage of reaction would undergo coil-to-globule transition to form very
tiny nuclei, which were stabilized by SDS; as the copolymerization
reaction proceeded, more poly(PEGDMA-co-DVB) fragments were
added onto the initially formed nuclei, leading to a continuous growth
in the size of the gel until the reaction was completed.5,11 Based on the
evolution of DLS intensity, the apparent rate constant k of 1.6 
102 min1 was derived from the fitting of the second-stage of the
time-dependent DLS intensity with an exponential growth (1st-order).
The kinetic evolution was further substantiated by in situ DLS
measurement of the average hydrodynamic diameter, hDhi, vs. reac-
tion time (Fig. S1 in ESI†). The k value increased to 2.8  102 and
4.3  102 min1, respectively, if the reaction temperature was set to
76.5 1C and 81.9 1C (see Fig. S2 and S3 in ESI† for kinetic curves).
Based on the linear fitting of ln k versus T1 (Fig. 1c) and the Arrhenius
equation
ln k = ln A  Ea/RT (1)
the activation energy (Ea) was determined to be 84.2 kJ mol
1.
However, a negligible effect of the reaction temperature on the
size of the produced nanogels was observed. The hDhi for the
nanogels was ca. 7.6 nm, as measured at 25.0 1C (Fig. 1d, also
see Fig. S4 and S5 in ESI†). The hDhi distribution shows only a
single peak for the narrowly distributed nanogels, with poly-
dispersity index m2/hGi2 = 0.001. Moreover, the TEM image
(Fig. 1e) indicates sphere-like morphology of the nanogels.
Since the conformational characteristic of the polymer chains is
a consequence of the counterbalance of the hydrophilic and hydro-
phobic forces in the polymers at a particular temperature,11 an
appropriate control of the feeding mol ratio fP–D of PEGDMA to DVB
should play a key role in the synthesis of such sub-10 nm nanogels
(Fig. 2a). The homopolymers of PEGDMA have a lower critical
solution temperature (LCST) as high as B90 1C.9 In our approach,
when a very high content of PEGDMA (fP–D Z 19.0; the feeding
amount of DVB was set to 2.8 103 mol L1, the same below) was
fed, the polymer chains may remain very hydrophilic and adopt a
random coil conformation, resulting in the formation of large
particles (hDhi Z 269.3 nm) or even bulky gels from the reaction.
An appropriate functionalization of the temperature-responsive
polymer with hydrophobic moieties should be able to reduce its
LCST.2c,11 When the fP–D was decreased to 9.0, a much smaller
nanogel of 36.2 nm was obtained. Interestingly, when the fP–D fell in
a quite wide range of 0.5–6.2, the size of the obtained nanogels can
be readily controlled to be very small (hDhi = 6.1–8.5 nm), demon-
strating a favourable window to synthesize sub-10 nm nanogels. All
nanogels were well reproducible from batch to batch, with a high
yield of Z89%. All nanogels show good stability, due to the highly
hydrophilic surface created by the ionic sulfate groups (SI1 and
Fig. S6 in ESI†) via using an extraordinary quantity of initiator APS in
the synthesis.2d No sediment was observed after 2 months storage at
ca. 25.0 1C. In contrast, at a very low fP–D (r0.3), the polymer chains
may became very hydrophobic to form large aggregates, leading to
the formation of large nanogels of hDhi Z 15.3 nm.
For a nanogel, the volume phase transition can be thought of as
the summation of the phase/conformational transitions of many
different sub-network chains inside the nanogel.12 Fig. 2b shows the
temperature-induced volume phase transitions of the nanogels dis-
persed in phosphate buffered solution (PBS; 5.0  103 mol L1,
pH = 7.4). It is clear that the temperature of dispersion medium can
influence the size of the nanogels (see Fig. S7 in ESI† for hDhiT
plots). More importantly, the equilibrium deswelling ratio, DSR =
hDhiT/hDhiT=201C, of the nanogels can be regulated by controlling the
fP–D, leading to a significant shift in the critical volume phase
transition temperature (VPTT) of the nanogels. The lower the fP–D
is, the lower the VPTT of the nanogels. For the nanogels synthesized
with a high fP–D of 19.0, the DSR remained nearly constant until the
temperature of above ca. 80 1C and then dropped, which confirms
that the sub-network polymer chains are indeed too hydrophilic to
undergo a coil-to-globule transition at 70 1C. While an appropriate
control of the fP–D at 9.0, 6.2, 3.0, and 1.5, respectively, resulted in a
continuous change in the DSR but in tunable slopes across 70 1C,
indicating different degrees of coil-to-globule transition of the sub-
network polymer chains at 70 1C, the nanogels synthesized with
fP–D = 0.1 exhibited a VPTT of ca. 25 1C, revealing that the sub-network
polymer chains should be very hydrophobic at 70 1C. The reversibility
Fig. 1 (a) Schematic illustration of the one-pot aqueous approach to prepare
sub-10 nm responsive nanogels. (b) Kinetic curve of SPN-1’s formation at 70.0 1C.
Solid line: 1st-order kinetic fit. (c) An Arrhenius plot for SPN-1. (d) DLS size
distribution of SPN-1 at 25.0 1C. (e) TEM image of SPN-1.
Fig. 2 (a) A plot of hDhi (measured at 25.0 1C) against fP–D. (b) Temperature-
dependent DSR of the nanogels synthesized with fP–D of: ’, 19.0; K, 9.0; m, 6.2;
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of the volume phase transition is demonstrated by the perfect match
of heating–cooling curves, as well as the repeatable size distribution
during heating–cooling cycles. Moreover, some types of the sub-
10 nm nanogels (e.g., SPN-1) can also exhibit a continuous change
in the DSR across the physiologically important temperature range of
37–42 1C, which is found in many pathological zones (e.g., tumor).13
Therefore, these results can not only provide direct experimental
proof of the conformational characteristic of the polymer chains at
the reaction temperature of 70 1C, but also foreshadow a responsive
nanocarrier with direct implications in biomedicine.
We carried out loading and release tests of 5-fluorouracil (5-FU),
a widely used anticancer drug,14 in order to evaluate the drug-
delivery performance of the sub-10 nm nanogels. The ether oxygens
of the PEGDMA units can form hydrogen bonds with the amide
groups in 5-FU molecules to form intermolecular complexes,15
resulting in a high drug loading efficiency. A drug loading capacity
of 59.8 wt% was determined for SPN-1. The nanogels had a narrow
size distribution with a negligible change in size after drug loading
(Fig. S8 in ESI†). The drug release from the nanogels was deter-
mined in PBS at different temperatures (Fig. 3a). The much slower
drug release from the nanogels than from the free drug solution
indicates a sustained release of 5-FU from the nanogels. The
temperature of the releasing medium can trigger the drug release.
The increase in temperature induces a gradual transition from
hydrophilic to hydrophobic polymer chains (Fig. 2b), which will
not only break the PEGDMA–5-FU hydrogen bond complexes and
enhance the mobility of guest 5-FU molecules, but also shrink the
mesh size of the nanogels so that the hydrophilic 5-FU molecules
are expelled and diffuse out of the gel. The release mechanism was
confirmed by analysis of the release profiles using Peppas’s model:16
Mt/MN = A0t
n (2)
where Mt and MN are the absolute cumulative amount of the drug
released at time t and infinite time, respectively. While n = 0.55 for
free 5-FU indicates a diffusion controlled transportation, the low n
values (for release at 37.0 1C and 42.0 1C, n = 0.24 and 0.33,
respectively, both of which are smaller than the critical value of
0.43 for spherical devices16) for the spherical nanogels demon-
strate that the release of 5-FU from the nanogels obeys two
correlated processes: one is a chemically controlled event related
to the breakage of hydrogen bonds; another is a diffusion-
controlled step.16 The investigated temperature variables did not
change the drug release mechanism. This release profile may be
exploited for biologically controlled drug delivery utilizing the
abnormal temperatures in pathological zones.13 Drug release by
a stepwise treatment can be achieved with surrounding tempera-
ture alternately changed between 37.0 and 42.0 1C (Fig. S9 in ESI†).
Interestingly, 5-FU released from the nanogels (Mt/MN E 15%
after 24 hours of release at 37.0 1C) has an unexpectedly high
anticancer activity with IC50 = 0.6 mg mL
1 (Fig. 3b and Fig. S10 in
ESI†; Fig. S11 indicates low-toxicity of empty nanogels, ESI†),
which is even lower than that of free 5-FU (IC50 = 1.9 mg mL
1;
Fig. S12 in ESI†). The improvement in anticancer activity of an
anticancer drug has been observed using responsive nanogels
with larger sizes (>20 nm).3–6,15 In our case, the temperature-
dependent cell viability assays indicated the potential use of sub-
10 nm nanogels as temperature-responsive carriers (Fig. S13 in
ESI†). Further, in comparison with the large nanogels (>20 nm),
sub-10 nm nanogels as carriers exhibited a significantly enhanced
anticancer activity (Fig. S14 in ESI†), implying another advantage
(besides being renal clearable, which is documented in the
literature4) of sub-10 nm nanogels over their large counterparts.
In conclusion, a simple free radical copolymerization of a
difunctional oligomer and a small-molecule crosslinker can provide
a versatile approach to prepare sub-10 nm responsive nanogels. It is
readily conducted at relatively high concentrations, making it a
practical approach for large-scale synthesis. This approach may
serve as a starting point for the synthesis of controllable and renal
clearable nanogel carriers with huge potential in biomedicine.
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